<HTML>
<HEAD>
<Title>Bioanalytical Systems, Inc. - Form S-8 - Incentive Stock Option Plan</title></head>
<BODY>

<hr noshade>
<p align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<b>UNITED STATES</b><br>
<b>SECURITIES AND EXCHANGE COMMISSION</b></FONT><br>
<FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<b>Washington, D.C. 20549</b><br><br></font></P>

<hr width=30% noshade>

<p align=center><FONT FACE="Times New Roman, Times, Serif" size=3>
<b>FORM S-8</b><BR>
<b>REGISTRATION STATEMENT UNDER</b><BR>
<b>THE SECURITIES ACT OF 1933</b></font></p>
<hr width=30% noshade>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<b><u>BIOANALYTICAL SYSTEMS, INC.</u></b><br>
<small><small>(Exact Name Of Registrant As Specified In Its Charter)</small></small>
</font></P>

<table width=100% border=0>
<tr valign=bottom>
<td width=50% align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<u><b>Indiana</b></u></font></td>
<td>&nbsp;</td>
<TD width=50% ALIGN=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<b><U>35-1345024</U></b></font></td></TR>

<TR VALIGN=TOP><TD ALIGN=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<small>(State or other jurisdiction of incorporation or organization)</small></font></TD>
<td>&nbsp;</td>
<td align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<small>(IRS Employer Identification No.)</small></font></td></TR>
</table>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<b>2701 Kent Avenue</b><BR>
<b><U>West Lafayette, Indiana 47906</U></b><BR>
<small>(Address of Principal Executive Offices)</small><BR>
</font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<b>Bioanalytical Systems, Inc. 1997 Employee</b><BR>
<b><U>Incentive Stock Option Plan</U></b><BR>
<small>(full title of the plan)</small></font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<b>Douglas P. Wieten</b><BR>
<b>Vice President-Finance, Chief Financial</b><BR>
<b>Officer and Treasurer</b><BR>
<b>Bioanalytical Systems, Inc.</b><BR>
<b>2701 Kent Avenue</b><BR>
<b><U>West Lafayette, Indiana 47906</U></b><BR>
<small>(Name and address of agent for service)</small>
</font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<b><U>(765) 463-4527</U></b><BR>
<small>(Telephone number, including</small><BR>
<small>area code, of agent for service)</small>
</font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Copies to:</font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<b>Stephen J. Hackman</b><BR>
<b>Ice Miller</b><BR>
<b>One American Square, Box 82001</b><BR>
<b>Indianapolis, Indiana 46282</b><BR></font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
<b>CALCULATION OF REGISTRATION FEE</b></font></P>

<hr noshade>
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD valign=bottom width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
Title of Securities<Br>
to be Registered</FONT></TD>

<TD valign=bottom width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
Amount to be<br>
Registered<sup>1</sup></FONT>
</TD>

<TD valign=bottom width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
Proposed Maximum<br>
Offering Price<br>
Per Unit<sup>2</sup></FONT>
</TD>

<TD valign=bottom width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
Proposed Maximum<br>
Aggregate Offering<br>
Price<sup>2</sup></FONT></TD>

<TD valign=bottom width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
Amount of<br>
Registration Fee</FONT></TD>
</tr>
</table>
<br>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
Common Stock</FONT></TD>

<TD width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
300,000 shares</FONT></TD>

<TD width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
$2.99
</FONT></TD>

<TD width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
$897,000
</FONT></TD>

<TD width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
$72.57
</FONT></TD>

</TR>
</TABLE>
<hr noshade>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR>
<TD valign=top WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
1</font></TD>
<TD WIDTH=95%><div align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
These are additional securities of the same class, to be offered pursuant to the
same employee  benefit plan as those  registered  pursuant to  Registration  No.
333-56123.  Pursuant to General  Instruction  E of Form S-8,  this  registration
statement covers only the additional shares being registered.</FONT></div></TD>
</TR>
</TABLE>
<BR>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR>
<TD valign=top WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
2</font></TD>
<TD WIDTH=95%><div align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
The registration fee has been calculated pursuant to Rule 457(c) and (h) based
upon the average of the high and low prices reported for the Common Stock on
March 7, 2003.</FONT></div></TD>
</TR>
</TABLE>

<PAGE>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<U>INFORMATION INCORPORATED BY REFERENCE</U></FONT></H1>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The contents of the registrant&#146;s  Registration  Statement on Form S-8, File
No.  333-56123,  heretofore  filed with the Securities  and Exchange  Commission
pursuant to the Securities Act of 1933, as amended,  are incorporated  herein by
reference.
</FONT></P>


<PAGE>


<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<U>SIGNATURES</U></FONT></H1>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Pursuant to the  requirements  of the  Securities  Act of 1933, as amended,  the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement  to be  signed  on  its  behalf  by  the  undersigned  thereunto  duly
authorized,   in  the   City  of  West   Lafayette,   State   of   Indiana,   on
March 10, 2003.
</FONT></P>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD WIDTH=60%>&nbsp;</TD>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
BIOANALYTICAL SYSTEMS, INC.<BR>
<BR>
<BR>
<BR>
By:&nbsp;&nbsp;&nbsp;/s/&nbsp;&nbsp;Peter T. Kissinger<HR>
Peter T. Kissinger, President and<BR>
Chief Executive Officer<BR>
</FONT>
</TD>
</TR>
</TABLE>
<BR>
<bR>


<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<U>POWER OF ATTORNEY</U></FONT></H1>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Know all men by these presents,
that each person whose signature appears below constitutes and appoints Peter T.
Kissinger,  his true and  lawful  attorney-in-fact  and agent with full power of
substitution and  re-substitution,  for him and in his name, place and stead, in
any and all  capacities,  to sign any and all  amendments  to this  Registration
Statement,  and to file the same, with all exhibits thereto, and other documents
in connection therewith,  with the Securities and Exchange Commission,  granting
unto this  attorney-in-fact and agent full power and authority to do and perform
each and every act and thing requisite and necessary to be done in and about the
premises,  as  fully  to all  intents  and  purposes  as he might or could do in
person,  hereby  ratifying and  confirming  all that this  attorney-in-fact  and
agent, or his substitute, may do or cause to be done by virtue hereof.
</FONT></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Pursuant to the  requirements of the Securities Act of 1933,  this  Registration
Statement has been signed by the following  persons in the capacities  indicated
on March 10, 2003.
</FONT></P>
<br>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/ Peter T. Kissinger<HR>
Peter T. Kissinger</FONT></TD>
<td width=20%>&nbsp;</td>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Chairman, President, Chief Executive Officer,<br>
and Director (Principal Executive Officer)</font></td>
</tr>
</table>
<br>
<br>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/ Douglas P. Wieten<HR>
Douglas P. Wieten</FONT></TD>
<td width=20%>&nbsp;</td>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Vice President-Finance, Chief Financial Officer<br>
and Treasurer (Principal Financial Officer and<br>
Principal Accounting Officer)</font></td>
</tr>
</table>
<br>
<br>

<PAGE>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/ Ronald E. Shoup<HR>
Ronald E. Shoup</FONT></TD>
<td width=20%>&nbsp;</td>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Director</font></td>
</tr>
</table>
<br>
<br>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/ Candice B. Kissinger<HR>
Candice B. Kissinger</FONT></TD>
<td width=20%>&nbsp;</td>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Director</font></td>
</tr>
</table>
<br>
<br>


<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/ William E. Baitinger<HR>
William E. Baitinger</FONT></TD>
<td width=20%>&nbsp;</td>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Director</font></td>
</tr>
</table>
<br>
<br>


<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/ John A. Kraeutler<HR>
John A. Kraeutler</FONT></TD>
<td width=20%>&nbsp;</td>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Director</font></td>
</tr>
</table>
<br>
<br>


<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/ W. Leigh Thompson<HR>
W. Leigh Thompson</FONT></TD>
<td width=20%>&nbsp;</td>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Director</font></td>
</tr>
</table>
<br>
<br>

<PAGE>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
BIOANALYTICAL SYSTEMS, INC.</FONT></H1>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
FORM S-8</FONT></H1>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
INDEX TO EXHIBITS</FONT></H1>
<br>
<br>


<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD width=25%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Exhibit Number<br>
Assigned in<br>
Regulation S-K<br>
<U>Item 601</U></font></div></td>
<td width=10%>&nbsp;</td>
<TD valign=bottom width=65%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>Description of Exhibit</U>
</FONT></div></TD>
</TR>
</TABLE>
<br>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD width=25%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
(4)</font></div></td>
<TD width=10%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;</font></div></td>
<TD width=65%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Not applicable</font></td></tr>
</table>
<br>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD width=25%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
(5)</font></div></td>
<TD width=10%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;</font></div></td>
<TD width=65%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Not applicable</font></td></tr>
</table>
<br>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD width=25%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
(15)</font></div></td>
<TD width=10%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;</font></div></td>
<TD width=65%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Not applicable</font></td></tr>
</table>
<br>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD width=25%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
(23)</font></div></td>
<TD width=10%><div align=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
23.01</font></div></td>
<TD width=65%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Consent of Ernst &amp; Young</font></td></tr>
</table>
<br>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD width=25%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
(99)</font></div></td>
<TD width=10%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;</font></div></td>
<TD width=65%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Not applicable</font></td></tr>
</table>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "bass8incentiveplan.htm", "description": "BIOANALYTICAL - INCENTIVE STOCK OPTION PLAN", "secsgml_size_bytes": 13354}]
{"company-data": {"conformed-name": "BIOANALYTICAL SYSTEMS INC", "cik": "0000720154", "assigned-sic": "8731", "irs-number": "351345024", "state-of-incorporation": "IN", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-103717", "film-number": "03598594"}, "business-address": {"street1": "2701 KENT AVE", "city": "WEST LAFAYETT", "state": "IN", "zip": "47906-1382", "phone": "3174634527"}, "mail-address": {"street1": "2701 KENT AVENUE", "city": "WEST LAFAYETTE", "state": "IN", "zip": "47906-1382"}}
Bioanalytical Systems, Inc. - Form S-8 - Incentive Stock Option Plan
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
BIOANALYTICAL SYSTEMS, INC.
(Exact Name Of Registrant As Specified In Its Charter)
Indiana
35-1345024
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
2701 Kent Avenue
West Lafayette, Indiana 47906
(Address of Principal Executive Offices)
Bioanalytical Systems, Inc. 1997 Employee
Incentive Stock Option Plan
(full title of the plan)
Douglas P. Wieten
Vice President-Finance, Chief Financial
Officer and Treasurer
Bioanalytical Systems, Inc.
2701 Kent Avenue
West Lafayette, Indiana 47906
(Name and address of agent for service)
(765) 463-4527
(Telephone number, including
area code, of agent for service)
Copies to:
Stephen J. Hackman
Ice Miller
One American Square, Box 82001
Indianapolis, Indiana 46282
CALCULATION OF REGISTRATION FEE
Title of Securities
to be Registered
Amount to be
Registered
1
Proposed Maximum
Offering Price
Per Unit
2
Proposed Maximum
Aggregate Offering
Price
2
Amount of
Registration Fee
Common Stock
300,000 shares
$2.99
$897,000
$72.57
1
These are additional securities of the same class, to be offered pursuant to the
same employee  benefit plan as those  registered  pursuant to  Registration  No.
333-56123.  Pursuant to General  Instruction  E of Form S-8,  this  registration
statement covers only the additional shares being registered.
2
The registration fee has been calculated pursuant to Rule 457(c) and (h) based
upon the average of the high and low prices reported for the Common Stock on
March 7, 2003.
INFORMATION INCORPORATED BY REFERENCE
The contents of the registrant's  Registration  Statement on Form S-8, File
No.  333-56123,  heretofore  filed with the Securities  and Exchange  Commission
pursuant to the Securities Act of 1933, as amended,  are incorporated  herein by
reference.
SIGNATURES
Pursuant to the  requirements  of the  Securities  Act of 1933, as amended,  the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement  to be  signed  on  its  behalf  by  the  undersigned  thereunto  duly
authorized,   in  the   City  of  West   Lafayette,   State   of   Indiana,   on
March 10, 2003.
BIOANALYTICAL SYSTEMS, INC.
By:   /s/  Peter T. Kissinger
Peter T. Kissinger, President and
Chief Executive Officer
POWER OF ATTORNEY
Know all men by these presents,
that each person whose signature appears below constitutes and appoints Peter T.
Kissinger,  his true and  lawful  attorney-in-fact  and agent with full power of
substitution and  re-substitution,  for him and in his name, place and stead, in
any and all  capacities,  to sign any and all  amendments  to this  Registration
Statement,  and to file the same, with all exhibits thereto, and other documents
in connection therewith,  with the Securities and Exchange Commission,  granting
unto this  attorney-in-fact and agent full power and authority to do and perform
each and every act and thing requisite and necessary to be done in and about the
premises,  as  fully  to all  intents  and  purposes  as he might or could do in
person,  hereby  ratifying and  confirming  all that this  attorney-in-fact  and
agent, or his substitute, may do or cause to be done by virtue hereof.
Pursuant to the  requirements of the Securities Act of 1933,  this  Registration
Statement has been signed by the following  persons in the capacities  indicated
on March 10, 2003.
/s/ Peter T. Kissinger
Peter T. Kissinger
Chairman, President, Chief Executive Officer,
and Director (Principal Executive Officer)
/s/ Douglas P. Wieten
Douglas P. Wieten
Vice President-Finance, Chief Financial Officer
and Treasurer (Principal Financial Officer and
Principal Accounting Officer)
/s/ Ronald E. Shoup
Ronald E. Shoup
Director
/s/ Candice B. Kissinger
Candice B. Kissinger
Director
/s/ William E. Baitinger
William E. Baitinger
Director
/s/ John A. Kraeutler
John A. Kraeutler
Director
/s/ W. Leigh Thompson
W. Leigh Thompson
Director
BIOANALYTICAL SYSTEMS, INC.
FORM S-8
INDEX TO EXHIBITS
Exhibit Number
Assigned in
Regulation S-K
Item 601
Description of Exhibit
(4)
Not applicable
(5)
Not applicable
(15)
Not applicable
(23)
23.01
Consent of Ernst & Young
(99)
Not applicable